Tatva Chintan Pharma Chem Ltd (TATV)

Currency in INR
1,144.75
+10.40(+0.92%)
Closed·

TATV Financial Summary

Key Ratios

P/E Ratio321.98
Price/Book3.63
Debt / Equity4.93%
Return on Equity0.77%
Dividend Yield0.18%
EBITDA342.13M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3.05%
Dividend Yield
0.18%
Industry Median 0.64%
Annualised payout
2.00
Paid annually
5-Years Growth
-
Growth Streak

Analyst Ratings

1 Buy
1 Hold
1 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 742.00
(-35.18% Downside)

Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
3.00 / --
Revenue / Forecast
1.18B / 1.27B
EPS Revisions
Last 90 days

FAQ

What were Tatva Chintan Pharma Chem's earnings for the latest quarter?

The Tatva Chintan Pharma Chem EPS (TTM) is 3.05. Tatva Chintan Pharma Chem reported sales of 1,091.80, net income of 51.33, and EPS of 3.00 for the latest quarter.

What was Tatva Chintan Pharma Chem's net income for the latest quarter?

Tatva Chintan Pharma Chem's net income for the latest quarter was 51.33.

How did Tatva Chintan Pharma Chem's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,078.64 in the previous quarter to 1,091.80 in the latest quarter, and net income moved from 10.30 to 51.33 compared to the previous quarter.

What is Tatva Chintan Pharma Chem's net profit margin on a TTM basis?

Tatva Chintan Pharma Chem's trailing twelve months (TTM) net profit margin is 1.49%.

How does Tatva Chintan Pharma Chem's debt to equity ratio compare to industry standards?

Tatva Chintan Pharma Chem's total debt-to-equity ratio is 4.93%.

What is Tatva Chintan Pharma Chem's return on investment on a TTM basis?

Tatva Chintan Pharma Chem's trailing twelve months (TTM) return on investment (ROI) is 0.77%.

How has Tatva Chintan Pharma Chem's total revenue grown this year?

Tatva Chintan Pharma Chem's total revenue was 1,078.64 in the previous quarter and 1,091.80 in the latest quarter.

What is Tatva Chintan Pharma Chem's gross margin on a TTM basis?

Tatva Chintan Pharma Chem's trailing twelve months (TTM) gross margin is 49.18%.

What was Tatva Chintan Pharma Chem's revenue per share for the latest quarter?

Tatva Chintan Pharma Chem's revenue per share for the latest quarter was 427.34.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.